Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide

Journal of Virology

Volumn 72, Issue 9, 1998, Pages 7084-7090

  Pope, M ^a   Marsden, P A ^a   Cole, E ^a   Sloan, S ^a   Fung, L S ^a   Ning, Q ^a   Ding, J W ^a   Leibowitz, J L ^b   Phillips, M J ^a   Levy, G A ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; N ACETYL S NITROSOPENICILLAMINE; N ACETYLPENICILLAMINE; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; MACROPHAGE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TITRATION;

EID: 0031846312     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.9.7084-7090.1998     Document Type: Article

References (46)

1. Chung, S., R. Gorczynski, B. Cruz, R. Fingerote, E. Skamene, S. Perlman, J. L. Leibowitz, L. S. Fung, M. Flowers, and G. A. Levy. 1994. A TH1 helper cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity (PCA) in vitro and protects against MHV-3 mortality in vivo. Immunology 83:353-361.
2. Croen, K. 1993. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex type 1 replication. J. Clin. Invest. 91:2446-2452.
3. Dindzans, V. J., E. Skamene, and G. A. Levy. 1986. Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two-non-H-2-linked genes. J. Immunol. 137:2355-2360.
4. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
5. Doi, T., M. Ando, T. Akaike, M. Suga, K. Sato, and H. Maeda. 1993. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect. Immun. 61:1980-1989.
6. Evans, R., and S. J. Kamdar. 1990. Stability of RNA isolated from macrophages depends on the removal of an RNA degrading activity early in the extraction procedure. BioTechniques 8:357-360.
7. Field, L., R. V. Dilts, R. Ravichandran, P. G. Lenhert, and G. E. Carnahan. 1978. An unusually stable thionitrite from N-acetyl-D,L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. J. Chem. Soc. Chem. Commun. 1978:249-250.
8. Flesch, I. E. A., J. H. Hess, I. P. Oswald, and S. H. E. Kaufmann. 1994. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int. Immunol. 6:693-700.
9. Granger, D. L. 1991. Macrophage production of nitrogen oxides in host defence against microorganisms. Res. Immunol. 142:570-572.
10. Green, L. C., K. R. DeLuzuriaga, D. A. Wagner, W. Rand, N. Istfan, V. R. Young, and S. R. Tannenbaum. 1981. Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. USA 78:7764-7768.
11. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
12. Green, S. J., M. S. Meltzer, J. B. Hibbs, and C. A. Nacy. 1990. Activated macrophages destroy Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-283.
13. Harbrecht, B. G., J. Stadler, A. J. Demetris, R. L. Simmons, and T. R. Billiar. 1994. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am. J. Physiol. 266(6 Pt. 1):G1004-G1010.
14. Harris, N. R., M. L. Buller, and G. Karupiah. 1995. Gamma-interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:910-915.
15. Hibbs, J. J., C. Westenfelder, R. Taintor, Z. Vavrim, C. Kablitz, R. L. Baranowski, J. H. Ward, R. L. Menlove, M. P, McMurry, and J. P. Kushner. 1992. Evidence for cytokine-inducible nitric oxide synthase from L-arginine in patients receiving interleukin-2 (IL-2) therapy. J. Clin. Invest. 89:867-877.
16. Hirano, M., K. Fujiwara, S. Hino, and M. Matumoto. 1974. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:298-302.
17. Holmes, K. V. 1990. Coronaviridae and their replication, p. 841-856. In B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman (ed.), Fields virology. Raven Press, New York, N.Y.
18. Karupiah, G., Q. Xie, M. L. Buller, C. Nathan, C. Duarte, and J. D. Mac-Micking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-1448.
19. Kwon, N. S., D. J. Stuehr, and C. F. Nathan. 1991. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174:761-767.
20. Lepoivre, M., B. Chenais, A. Yapo, G. Lemaire, L. Thelander, and J. P. Tenu. 1990. Alterations of ribonuclcotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265: 14143-14149.
21. Levy, G. A., J. L. Leibowitz, and T. S. Edgington. 1981. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J. Exp. Med. 154:1150-1163.
22. Li, C., L. S. Fung, A. Crow, N. Myers-Mason, J. L. Leibowitz, E. Cole, and G. A. Levy. 1992. Monoclonal anti-prothrombinase (3D4.3) prevents mortality from murine hepatitis virus infection (MHV-3). J. Exp. Med. 1763: 689-697.
23. Liew, F. Y., Y. Li, D. Moss, C. Parkinson, M. V. Rogers, and S. Moncada. 1991. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21:3009-3014.
24. Lucchiari, M. A., M. Modolell, K. Eichmann, and C. A. Pereira. 1992. In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection. Immunobiology 185:475-482.
25. Lucchiari, M. A., J. P. Martin, M. Modolell, and C. A. Pereira. 1991. Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence of interferon-gamma synthesis and macrophage sensitivity to interferon-gamma. J. Gen. Virol. 72:1317-1322.
26. Lyons, C. R., G. J. Orloff, and J. M. Cunningham. 1992. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267:6370-6374.
27. Macnaughton, M. R., and S. Patterson. 1980. Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages. Arch. Virol. 66:71-75.
28. Manuel, J., S. B. Corradin, and Y. Buchmuller Rouiller. 1991. Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages. Res. Immunol. 142:577-579.
29. Mello, I. G. C., R. C. Vassao, and C. A. Pereira. 1993. Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV-3. Arch. Virol. 132:281-289.
30. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric-oxide dependent mechanism. Immunol. Lett. 33:35-40.
31. Nacy, C. A., B. J. Nelson, M. S. Meltzer, and S. J. Green. 1991. Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities. Res. Immunol. 142:573-576.
32. Nakamura, L. T., B. A. Wu-Hsieh, and D. H. Howard. 1994. Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immun. 62: 680-684.
33. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
34. Ning, Q., D. Brown, J. Parodo, M. Cattral, R. Gorczynski, E. Cole, L. S. Fung, J. W. Ding, M. F. Liu, O. Rotstein, M. J. Phillips, and G. A. Levy. 1997. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1. the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 160:3487-3493.
35. Pereira, C. A., M. A. Lucchiari, M. Modolell, L. Kuhn, and I. Lefkovits. 1993. An attempt to identify gene products related to the induction of an antiviral State in macrophages resistant and sensitive to IFN-gamma. Res. Virol. 144:479-486.
36. Pope, M., O. Rotstein, E. Cole, S. Sinclair, R. Parr, B. Cruz, R. Fingerote, S. Chung, R. Gorczynski, L. Fung, J. Leibowitz, Y. S. Rao, and G. Levy. 1995. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J. Virol. 69:5252-5260.
37. Raschke, W. C., S. Baird, P. Ralph, and I. Nakooinz. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261-267.
38. Stamler, J. S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936.
39. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
40. Sturman, L. S., and K. K. Takemoto. 1972. Enhanced growth of a murine coronavirus in transformed mouse cells. Infect. Immun. 6:501-507.
41. Tanaka, K., H. Nakazawa, K. Okada, K. Umezawa, N. Fukuyama, and Y. Koga. 1997. Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus. J. Clin. Invest. 100:1822-1830.
42. Tokunaga, K., Y. Nakamura, K. Sakata, K. Fujimori, M. Ohkubo, K. Sawada, and S. Sakiyana. 1987. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 47: 5616-5619.
43. Wang, Y., and P. A. Marsden. 1995. Nitric oxide synthases: biochemical and molecular regulation. Curr. Opin. Nephrol. Hypertens. 4:12-22.
44. Weisz, A., S. Oguchi, L. Gratiello, and H. Esumi. 1994. Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J. Biol. Chem. 269:8324-8333.
45. Xie, Q. W., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-gamma and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
46. Zaragoza, C., C. J. Ocampo, M. Saura, A. McMillan, and C. J. Lowenstein. 1997. Nitric oxide inhibition of coxsackievirus replication in vitro. J Clin. Invest. 100:1760-1767.